Anthelmycin

DB20238ExperimentalSmall molecule

Anthelmycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Anthelmycin is a antibiotic, produced by Streptomyces strain. Anthelmycin has a monoisotopic...

Mechanism: Pharmacologically active on 23S ribosomal RNA
Curator reviewed
Formula / weight: C₂₁H₃₇N₅O₁₄ · 583.548 g/mol (avg)
Also known as: Antelmycin
Code names: NSC-337588

Resolves to

Compound

UNII7PB008085SCAS12706-94-4ChEMBLCHEMBL3989421ChEBI88275

Structure

InChIKeyVQQSDVBOXQHCHU-SKPOXZENSA-NSMILES

[H][C@@](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O)([C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)[C@@]1([H])O[C@H]([C@H](O)[C@@H](O)[C@@H]1N)N1C=CC(N)=NC1=O

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Anthelmycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account